TrialPharmacology research & perspectives2021

A phase I, single and continuous dose administration study on the safety, tolerability, and pharmacokinetics of neorudin, a novel recombinant anticoagulant protein, in healthy subjects.

Yubin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.